메뉴 건너뛰기




Volumn 19, Issue 29, 2013, Pages 5177-5192

Cardiovascular and systemic risk in nonalcoholic fatty liver disease -Atherosclerosis as a major player in the natural course of NAFLD

Author keywords

Atherosclerosis; Cholangiocarcinoma; Chronic kidney disease; Cirrhosis; Colorectal cancer; HCC; Mortality; NAFLD; NASH; Natural history; Type 2 diabetes

Indexed keywords

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BILE DUCT CARCINOMA; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COLONOSCOPY; COLORECTAL CANCER; DIABETOGENESIS; DISEASE COURSE; HEALTH HAZARD; HEPATITIS; HEPATOBILIARY SYSTEM CANCER; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER TRANSPLANTATION; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 84881232944     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319290003     Document Type: Article
Times cited : (110)

References (193)
  • 1
    • 0019152816 scopus 로고
    • Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
    • Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-38.
    • (1980) Mayo Clin Proc , vol.55 , pp. 434-438
    • Ludwig, J.1    Viggiano, T.R.2    McGill, D.B.3    Oh, B.J.4
  • 2
    • 0025178612 scopus 로고
    • The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years
    • Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74-80.
    • (1990) Hepatology , vol.11 , pp. 74-80
    • Powell, E.E.1    Cooksley, W.G.2    Hanson, R.3    Searle, J.4    Halliday, J.W.5    Powell, L.W.6
  • 3
    • 0028875908 scopus 로고
    • The natural history of nonalcoholic fatty liver: A follow-up study
    • Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995; 22: 1714-19.
    • (1995) Hepatology , vol.22 , pp. 1714-1719
    • Teli, M.R.1    James, O.F.2    Burt, A.D.3    Bennett, M.K.4    Day, C.P.5
  • 4
    • 84861543083 scopus 로고    scopus 로고
    • The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
    • Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005-23.
    • (2012) Hepatology , vol.55 , pp. 2005-2023
    • Chalasani, N.1    Younossi, Z.2    Lavine, J.E.3
  • 5
    • 80555136061 scopus 로고    scopus 로고
    • Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
    • Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011; 43: 617-49.
    • (2011) Ann Med , vol.43 , pp. 617-649
    • Musso, G.1    Gambino, R.2    Cassader, M.3    Pagano, G.4
  • 7
    • 0344099066 scopus 로고    scopus 로고
    • Prognosis of patients with a diagnosis of fatty liver - a registry-based cohort study
    • Jepsen P, Vilstrup H, Mellemkjaer L, et al. Prognosis of patients with a diagnosis of fatty liver - a registry-based cohort study. Hepatogastroenterology 2003; 50: 2101-4.
    • (2003) Hepatogastroenterology , vol.50 , pp. 2101-2104
    • Jepsen, P.1    Vilstrup, H.2    Mellemkjaer, L.3
  • 8
    • 22344452893 scopus 로고    scopus 로고
    • The natural history of nonalcoholic fatty liver disease: A population-based cohort study
    • Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-21.
    • (2005) Gastroenterology , vol.129 , pp. 113-121
    • Adams, L.A.1    Lymp, J.F.2    Sauver, S.J.3
  • 9
    • 33750606061 scopus 로고    scopus 로고
    • Long-term follow-up of patients with NAFLD and elevated liver enzymes
    • Ekstedt M, Franzén LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44: 865-73.
    • (2006) Hepatology , vol.44 , pp. 865-873
    • Ekstedt, M.1    Franzén, L.E.2    Mathiesen, U.L.3
  • 10
    • 50549084740 scopus 로고    scopus 로고
    • Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
    • Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatology 2008; 49: 608-12.
    • (2008) J Hepatology , vol.49 , pp. 608-612
    • Ong, J.P.1    Pitts, A.2    Younossi, Z.M.3
  • 11
    • 50649094716 scopus 로고    scopus 로고
    • Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study
    • Dunn W, Xu R, Wingard DL, et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008; 103: 2263-71.
    • (2008) Am J Gastroenterol , vol.103 , pp. 2263-2271
    • Dunn, W.1    Xu, R.2    Wingard, D.L.3
  • 12
    • 72949097025 scopus 로고    scopus 로고
    • Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels
    • Haring R, Wallaschofski H, Nauck M, Dörr M, Baumeister SE, Völzke H. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepatology 2009; 50: 1403-11.
    • (2009) Hepatology , vol.50 , pp. 1403-1411
    • Haring, R.1    Wallaschofski, H.2    Nauck, M.3    Dörr, M.4    Baumeister, S.E.5    Völzke, H.6
  • 13
    • 75449088414 scopus 로고    scopus 로고
    • Decreased survival of subjects with elevated liver function tests during a 28 year follow up
    • Söderberg C, Stål P, Askling J, et al. Decreased survival of subjects with elevated liver function tests during a 28 year follow up. Hepatology 2010; 51: 595-602.
    • (2010) Hepatology , vol.51 , pp. 595-602
    • Söderberg, C.1    Stål, P.2    Askling, J.3
  • 14
    • 79957462315 scopus 로고    scopus 로고
    • Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease
    • Sookoian S, Pirola CJ. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 2011; 53: 1883-94.
    • (2011) Hepatology , vol.53 , pp. 1883-1894
    • Sookoian, S.1    Pirola, C.J.2
  • 15
    • 78650876710 scopus 로고    scopus 로고
    • Alcohol consumption appears to protect against non-alcoholic fatty liver disease
    • Moriya A, Iwasaki Y, Ohguchi S, et al. Alcohol consumption appears to protect against non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2011; 33: 378-88.
    • (2011) Aliment Pharmacol Ther , vol.33 , pp. 378-388
    • Moriya, A.1    Iwasaki, Y.2    Ohguchi, S.3
  • 16
    • 79959541652 scopus 로고    scopus 로고
    • Fatty liver index and mortality: The Cremona study in the 15th year of follow-up
    • Calori G, Lattuada G, Ragogna F, et al. Fatty liver index and mortality: the Cremona study in the 15th year of follow-up. Hepatology 2011; 54: 145-52.
    • (2011) Hepatology , vol.54 , pp. 145-152
    • Calori, G.1    Lattuada, G.2    Ragogna, F.3
  • 17
    • 33751246499 scopus 로고    scopus 로고
    • The Fatty Liver Index: A simple and accurate predictor of hepatic steatosis in the general population
    • Bedogni G, Bellentani S, Miglioli L, et al The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006; 6: 33.
    • (2006) BMC Gastroenterol , vol.6 , pp. 33
    • Bedogni, G.1    Bellentani, S.2    Miglioli, L.3
  • 18
    • 83755178774 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease and mortality among US adults: Prospective cohort study
    • Lazo M, Hernaez R, Bonekamp S, et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011; 343: d6891.
    • (2011) BMJ , vol.343
    • Lazo, M.1    Hernaez, R.2    Bonekamp, S.3
  • 19
    • 75449102165 scopus 로고    scopus 로고
    • Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance?
    • Erratum in: Hepatology 2010; 51: 1868
    • Angulo P. Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology 2010; 51: 373-5. Erratum in: Hepatology 2010; 51: 1868.
    • (2010) Hepatology , vol.51 , pp. 373-375
    • Angulo, P.1
  • 22
    • 0036724436 scopus 로고    scopus 로고
    • Non-alcoholic steatohepatitis: A common cause of progressive chronic liver injury?
    • Evans CD, Oien KA, MacSween RN, Mills PR. Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury? J Clin Pathol 2002; 55: 689-92.
    • (2002) J Clin Pathol , vol.55 , pp. 689-692
    • Evans, C.D.1    Oien, K.A.2    Macsween, R.N.3    Mills, P.R.4
  • 23
    • 0043268063 scopus 로고    scopus 로고
    • Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C
    • Hui JM, Kench JG, Chitturi S, Sud A, et al. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 2003; 38: 420-27.
    • (2003) Hepatology , vol.38 , pp. 420-427
    • Hui, J.M.1    Kench, J.G.2    Chitturi, S.3    Sud, A.4
  • 24
    • 33645963121 scopus 로고    scopus 로고
    • Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C
    • Sanyal AJ, Banas C, Sargeant C, et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Hepatology 2006; 43: 682-89.
    • (2006) Hepatology , vol.43 , pp. 682-689
    • Sanyal, A.J.1    Banas, C.2    Sargeant, C.3
  • 25
    • 58849132440 scopus 로고    scopus 로고
    • Clinical features and outcomes of cirrhosis due to nonalcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C
    • Yatsuji S, Hashimoto E, Tobari M, Taniai M, Tokushige K, Shiratori K. Clinical features and outcomes of cirrhosis due to nonalcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. J Gastroenterol Hepatol 2009; 24: 248-54.
    • (2009) J Gastroenterol Hepatol , vol.24 , pp. 248-254
    • Yatsuji, S.1    Hashimoto, E.2    Tobari, M.3    Taniai, M.4    Tokushige, K.5    Shiratori, K.6
  • 28
    • 67649306197 scopus 로고    scopus 로고
    • Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
    • Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol 2009; 51: 371-7.
    • (2009) J Hepatol , vol.51 , pp. 371-377
    • Argo, C.K.1    Northup, P.G.2    Al-Osaimi, A.M.3    Caldwell, S.H.4
  • 29
    • 0031947715 scopus 로고    scopus 로고
    • Steatohepatitis: A tale of two hits?
    • Day CP, James OF. Steatohepatitis: a tale of two hits? Gastroenterology 1998; 114: 842-5.
    • (1998) Gastroenterology , vol.114 , pp. 842-845
    • Day, C.P.1    James, O.F.2
  • 30
    • 77952517940 scopus 로고    scopus 로고
    • Clinical physiology of NAFLD: A critical overview of pathogenesis and treatment
    • Lonardo A, Caldwell SH, Loria P. Clinical physiology of NAFLD: a critical overview of pathogenesis and treatment. Expert Rev Endocrinol Metab 2010; 5: 403-23.
    • (2010) Expert Rev Endocrinol Metab , vol.5 , pp. 403-423
    • Lonardo, A.1    Caldwell, S.H.2    Loria, P.3
  • 31
    • 78049522194 scopus 로고    scopus 로고
    • Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
    • Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010; 52: 1836-46.
    • (2010) Hepatology , vol.52 , pp. 1836-1846
    • Tilg, H.1    Moschen, A.R.2
  • 32
    • 61949153022 scopus 로고    scopus 로고
    • Burning hepatic fat: Therapeutic potential for liverspecific thyromimetics in the treatment of nonalcoholic fatty liver disease
    • Arrese M. Burning hepatic fat: therapeutic potential for liverspecific thyromimetics in the treatment of nonalcoholic fatty liver disease. Hepatology 2009; 49: 348-51.
    • (2009) Hepatology , vol.49 , pp. 348-351
    • Arrese, M.1
  • 33
    • 79954548597 scopus 로고    scopus 로고
    • Insulin resistance in nonalcoholic steatohepatitis: Necessary but not sufficient death of a dogma from analysis of therapeutic studies?
    • Lonardo A, Bellentani S, Ratziu V, Loria P. Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient death of a dogma from analysis of therapeutic studies? Exp Rev Gastroenterol Hepatol 2011; 5: 279-89.
    • (2011) Exp Rev Gastroenterol Hepatol , vol.5 , pp. 279-289
    • Lonardo, A.1    Bellentani, S.2    Ratziu, V.3    Loria, P.4
  • 34
    • 65949090538 scopus 로고    scopus 로고
    • Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes
    • Ricchi M, Odoardi MR, Carulli L, et al. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. J Gastroenterol Hepatol 2009; 24: 830-40.
    • (2009) J Gastroenterol Hepatol , vol.24 , pp. 830-840
    • Ricchi, M.1    Odoardi, M.R.2    Carulli, L.3
  • 35
    • 80053612479 scopus 로고    scopus 로고
    • Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis
    • Van Rooyen DM, Larter CZ, Haigh WG, et al. Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis. Gastroenterology 2011; 141: 1393-403.
    • (2011) Gastroenterology , vol.141 , pp. 1393-1403
    • van Rooyen, D.M.1    Larter, C.Z.2    Haigh, W.G.3
  • 36
    • 80052501527 scopus 로고    scopus 로고
    • Hyperuricemia is associated with histological liver damage in patients with nonalcoholic fatty liver disease
    • Petta S, Cammà C, Cabibi D, Di Marco V, Craxì A. Hyperuricemia is associated with histological liver damage in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2011; 34: 757-66.
    • (2011) Aliment Pharmacol Ther , vol.34 , pp. 757-766
    • Petta, S.1    Cammà, C.2    Cabibi, D.3    Di Marco, V.4    Craxì, A.5
  • 37
    • 79956117037 scopus 로고    scopus 로고
    • Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity
    • Fracanzani AL, Valenti L, Bugianesi E, et al. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. J Hepatol 2011; 54: 1244-49.
    • (2011) J Hepatol , vol.54 , pp. 1244-1249
    • Fracanzani, A.L.1    Valenti, L.2    Bugianesi, E.3
  • 38
    • 84878323948 scopus 로고    scopus 로고
    • Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?
    • May
    • Carulli L, Ballestri S, Lonardo A, et al. Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? Intern Emerg Med 2011 May 11.
    • (2011) Intern Emerg Med , pp. 11
    • Carulli, L.1    Ballestri, S.2    Lonardo, A.3
  • 40
    • 79953212588 scopus 로고    scopus 로고
    • Gruppo Italiano Patologi Apparato Digerente (GIPAD); Società Italiana di Anatomia Patologica e Citopatologia Diagnostica/International Academy of Pathology, Italian division (SIAPEC/IAP). Chronic viral hepatitis: The histology report
    • ] Guido M, Mangia A, Faa G; Gruppo Italiano Patologi Apparato Digerente (GIPAD); Società Italiana di Anatomia Patologica e Citopatologia Diagnostica/International Academy of Pathology, Italian division (SIAPEC/IAP). Chronic viral hepatitis: the histology report. Dig Liver Dis 2011; 43 (suppl 4): S331-43.
    • (2011) Dig Liver Dis , vol.43 , Issue.4 SUPPL. , pp. 331-343
    • Guido, M.1    Mangia, A.2    Faa, G.3
  • 41
    • 78649433367 scopus 로고    scopus 로고
    • Histopathology of nonalcoholic fatty liver disease
    • Brunt EM, Tiniakos DG. Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16: 5286-96.
    • (2010) World J Gastroenterol , vol.16 , pp. 5286-5296
    • Brunt, E.M.1    Tiniakos, D.G.2
  • 42
    • 70349238777 scopus 로고    scopus 로고
    • Adipokines in liver diseases
    • Marra F, Bertolani C. Adipokines in liver diseases. Hepatology 2009; 50: 957-69.
    • (2009) Hepatology , vol.50 , pp. 957-969
    • Marra, F.1    Bertolani, C.2
  • 43
    • 84872671526 scopus 로고    scopus 로고
    • Liver and diabetes. A vicious circle
    • [] Loria P, Lonardo A, Anania F. Liver and diabetes. A vicious circle. Hepatol Res 2013; 43:51-64.
    • (2013) Hepatol , Issue.43 , pp. 51-64
    • Loria, P.1    Lonardo, A.2    Anania, F.3
  • 44
    • 46449131992 scopus 로고    scopus 로고
    • Is liver fat detrimental to vessels?: Intersections in the pathogenesis of NAFLD and atherosclerosis
    • Loria P, Lonardo A, Targher G. Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis. Clin Sci (Lond) 2008; 115: 1-12.
    • (2008) Clin Sci (Lond) , vol.115 , pp. 1-12
    • Loria, P.1    Lonardo, A.2    Targher, G.3
  • 45
    • 77957375969 scopus 로고    scopus 로고
    • Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease
    • Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363: 1341-50.
    • (2010) N Engl J Med , vol.363 , pp. 1341-1350
    • Targher, G.1    Day, C.P.2    Bonora, E.3
  • 46
    • 77951456114 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection
    • Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection. Hepatology 2010; 51: 1820-32.
    • (2010) Hepatology , vol.51 , pp. 1820-1832
    • Starley, B.Q.1    Calcagno, C.J.2    Harrison, S.A.3
  • 47
    • 75349084543 scopus 로고    scopus 로고
    • Risk of HCC: Genetic heterogeneity and complex genetics
    • Dragani TA. Risk of HCC: genetic heterogeneity and complex genetics. J Hepatol 2010; 52: 252-7.
    • (2010) J Hepatol , vol.52 , pp. 252-257
    • Dragani, T.A.1
  • 48
    • 80052661748 scopus 로고    scopus 로고
    • Iron overload in nonalcoholic steatohepatitis
    • Fujita N, Takei Y. Iron overload in nonalcoholic steatohepatitis. Adv Clin Chem 2011; 55: 105-32.
    • (2011) Adv Clin Chem , vol.55 , pp. 105-132
    • Fujita, N.1    Takei, Y.2
  • 49
    • 75749085257 scopus 로고    scopus 로고
    • Insulin resistance, type 2 diabetes and chronic liver disease. A deadly trio
    • Lonardo A, Loria P. Insulin resistance, type 2 diabetes and chronic liver disease. A deadly trio. Clinical Medicine: Endocrinology and Diabetes 2009: 281-88.
    • (2009) Clinical Medicine: Endocrinology and Diabetes , pp. 281-288
    • Lonardo, A.1    Loria, P.2
  • 50
    • 0037464510 scopus 로고    scopus 로고
    • Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults
    • Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. Engl J Med 2003; 348: 1625-38.
    • (2003) Engl J Med , vol.348 , pp. 1625-1638
    • Calle, E.E.1    Rodriguez, C.2    Walker-Thurmond, K.3    Thun, M.J.4
  • 52
    • 34247869042 scopus 로고    scopus 로고
    • The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas
    • Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007; 132: 2208-25.
    • (2007) Gastroenterology , vol.132 , pp. 2208-2225
    • Giovannucci, E.1    Michaud, D.2
  • 53
    • 0036302288 scopus 로고    scopus 로고
    • Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma
    • Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002; 123: 134-40.
    • (2002) Gastroenterology , vol.123 , pp. 134-140
    • Bugianesi, E.1    Leone, N.2    Vanni, E.3
  • 55
  • 56
    • 70450235099 scopus 로고    scopus 로고
    • HCV infection and cryptogenic cirrhosis are risk factors for hepatocellular carcinoma among Latinos in New York City
    • Guerrero-Preston R, Siegel A, Renz J, Vlahov D, Neugut A. HCV infection and cryptogenic cirrhosis are risk factors for hepatocellular carcinoma among Latinos in New York City. J Community Health 2009; 34: 500-5.
    • (2009) J Community Health , vol.34 , pp. 500-505
    • Guerrero-Preston, R.1    Siegel, A.2    Renz, J.3    Vlahov, D.4    Neugut, A.5
  • 57
    • 80052365527 scopus 로고    scopus 로고
    • Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria
    • Takuma Y, Nouso K, Makino Y, et al. Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria. J Gastroenterol Hepatol 2011; 26: 1417-24.
    • (2011) J Gastroenterol Hepatol , vol.26 , pp. 1417-1424
    • Takuma, Y.1    Nouso, K.2    Makino, Y.3
  • 58
    • 79960445939 scopus 로고    scopus 로고
    • Liver cirrhosis in Malaysia: Peculiar epidemiology in a multiracial Asian country
    • Qua CS, Goh KL. Liver cirrhosis in Malaysia: peculiar epidemiology in a multiracial Asian country. J Gastroenterol Hepatol 2011; 26: 1333-37.
    • (2011) J Gastroenterol Hepatol , vol.26 , pp. 1333-1337
    • Qua, C.S.1    Goh, K.L.2
  • 59
    • 55549106451 scopus 로고    scopus 로고
    • Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?
    • Guzman G, Brunt EM, Petrovic LM, Chejfec G, Layden TJ, Cotler SJ. Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? Arch Pathol Lab Med 2008; 132: 1761-66.
    • (2008) Arch Pathol Lab Med , vol.132 , pp. 1761-1766
    • Guzman, G.1    Brunt, E.M.2    Petrovic, L.M.3    Chejfec, G.4    Layden, T.J.5    Cotler, S.J.6
  • 60
    • 71049127867 scopus 로고    scopus 로고
    • Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?
    • Chagas AL, Kikuchi LO, Oliveira CP, et al. Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients? Braz J Med Biol Res 2009; 42: 958-62.
    • (2009) Braz J Med Biol Res , vol.42 , pp. 958-962
    • Chagas, A.L.1    Kikuchi, L.O.2    Oliveira, C.P.3
  • 61
    • 63349085247 scopus 로고    scopus 로고
    • Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis
    • Paradis V, Zalinski S, Chelbi E, et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 2009; 49: 851-59.
    • (2009) Hepatology , vol.49 , pp. 851-859
    • Paradis, V.1    Zalinski, S.2    Chelbi, E.3
  • 62
    • 84895071018 scopus 로고    scopus 로고
    • The emerging impact of HCC-NAFLD in Italy
    • Bellentani S, Brachetti A, Dionigi E, et al. The emerging impact of HCC-NAFLD in Italy. Dig Liver Dis 2012; 44 suppl: S9.
    • (2012) Dig Liver Dis , vol.44 , Issue.SUPPL.
    • Bellentani, S.1    Brachetti, A.2    Dionigi, E.3
  • 63
    • 82455168095 scopus 로고    scopus 로고
    • Surveillance for hepatocellular carcinoma: A standard of care, not a clinical option
    • Sangiovanni A, Colombo M. Surveillance for hepatocellular carcinoma: a standard of care, not a clinical option. Hepatology 2011; 54: 1898-900.
    • (2011) Hepatology , vol.54 , pp. 1898-1900
    • Sangiovanni, A.1    Colombo, M.2
  • 64
    • 79960747094 scopus 로고    scopus 로고
    • Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-Medicare database
    • Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology 2011; 54: 463-71.
    • (2011) Hepatology , vol.54 , pp. 463-471
    • Welzel, T.M.1    Graubard, B.I.2    Zeuzem, S.3    El-Serag, H.B.4    Davila, J.A.5    McGlynn, K.A.6
  • 65
    • 84860215803 scopus 로고    scopus 로고
    • Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults
    • Borena W, Strohmaier S, Lukanova A, et al. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. Int J Cancer 2012; 131: 193-200.
    • (2012) Int J Cancer , vol.131 , pp. 193-200
    • Borena, W.1    Strohmaier, S.2    Lukanova, A.3
  • 66
    • 0347926486 scopus 로고    scopus 로고
    • Risk of cancer in patients hospitalized with fatty liver: A Danish cohort study
    • Sørensen HT, Mellemkjaer L, Jepsen P, et al. Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study. J Clin Gastroenterol 2003; 36: 356-9.
    • (2003) J Clin Gastroenterol , vol.36 , pp. 356-359
    • Sørensen, H.T.1    Mellemkjaer, L.2    Jepsen, P.3
  • 67
    • 77649226704 scopus 로고    scopus 로고
    • Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps
    • Hwang ST, Cho YK, Park JH, et al. Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps. J Gastroenterol Hepatol 2010; 25: 562-7.
    • (2010) J Gastroenterol Hepatol , vol.25 , pp. 562-567
    • Hwang, S.T.1    Cho, Y.K.2    Park, J.H.3
  • 68
    • 79955804203 scopus 로고    scopus 로고
    • High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis
    • Wong VW, Wong GL, Tsang SW, et al. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut 2011; 60: 829-36.
    • (2011) Gut , vol.60 , pp. 829-836
    • Wong, V.W.1    Wong, G.L.2    Tsang, S.W.3
  • 69
    • 79959344354 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: An independent risk factor for colorectal neoplasia
    • Stadlmayr A, Aigner E, Steger B, et al. Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia. J Intern Med 2011; 270: 41-9.
    • (2011) J Intern Med , vol.270 , pp. 41-49
    • Stadlmayr, A.1    Aigner, E.2    Steger, B.3
  • 70
    • 77649340353 scopus 로고    scopus 로고
    • A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee
    • Loria P, Adinolfi LE, Bellentani S, et al. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis 2010; 42: 272-82.
    • (2010) Dig Liver Dis , vol.42 , pp. 272-282
    • Loria, P.1    Adinolfi, L.E.2    Bellentani, S.3
  • 71
    • 36248987256 scopus 로고    scopus 로고
    • A casecontrol study of non-alcoholic fatty liver disease in breast cancer
    • Bilici A, Ozguroglu M, Mihmanli I, Turna H, Adaletli I. A casecontrol study of non-alcoholic fatty liver disease in breast cancer. Med Oncol 2007; 24: 367-71.
    • (2007) Med Oncol , vol.24 , pp. 367-371
    • Bilici, A.1    Ozguroglu, M.2    Mihmanli, I.3    Turna, H.4    Adaletli, I.5
  • 72
    • 79955860802 scopus 로고    scopus 로고
    • NAFLD and extrahepatic cancers: Have a look at the colon
    • Tilg H, Diehl AM. NAFLD and extrahepatic cancers: have a look at the colon. Gut 2011; 60: 745-6.
    • (2011) Gut , vol.60 , pp. 745-746
    • Tilg, H.1    Diehl, A.M.2
  • 73
    • 0035079416 scopus 로고    scopus 로고
    • Sugar pills for pancreatic cancer: The benefits of becoming (insulin) sensitive
    • Diehl AM. Sugar pills for pancreatic cancer: the benefits of becoming (insulin) sensitive. Gastroenterology 2001; 120: 1291-6.
    • (2001) Gastroenterology , vol.120 , pp. 1291-1296
    • Diehl, A.M.1
  • 74
    • 20444384546 scopus 로고    scopus 로고
    • Gallstone disease in nonalcoholic fatty liver: Prevalence and associated factors
    • Loria P, Lonardo A, Lombardini S, et al. Gallstone disease in nonalcoholic fatty liver: prevalence and associated factors. J Gastroenterol Hepatol 2005; 20: 1176-84.
    • (2005) J Gastroenterol Hepatol , vol.20 , pp. 1176-1184
    • Loria, P.1    Lonardo, A.2    Lombardini, S.3
  • 75
    • 0021718875 scopus 로고
    • Fecal bile acid excretion in patients with colon cancer, colon polyp and peptic ulcer
    • Makino T. Fecal bile acid excretion in patients with colon cancer, colon polyp and peptic ulcer. Tokai J Exp Clin Med 1984; 9: 297-305.
    • (1984) Tokai J Exp Clin Med , vol.9 , pp. 297-305
    • Makino, T.1
  • 76
    • 0026240184 scopus 로고
    • Faecal bile acids and colorectal cell proliferation
    • The ECP Colon Cancer Working Group
    • ] Biasco G, Paganelli GM, Owen RW, Hill MJ. Faecal bile acids and colorectal cell proliferation. The ECP Colon Cancer Working Group. Eur J Cancer Prev 1991; suppl 2: 63-8.
    • (1991) Eur J Cancer Prev , Issue.2 SUPPL. , pp. 63-68
    • Biasco, G.1    Paganelli, G.M.2    Owen, R.W.3    Hill, M.J.4
  • 77
    • 0036263238 scopus 로고    scopus 로고
    • High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes
    • Vozarova B, Stefan N, Lindsay RS, et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002; 51: 1889-95.
    • (2002) Diabetes , vol.51 , pp. 1889-1895
    • Vozarova, B.1    Stefan, N.2    Lindsay, R.S.3
  • 78
    • 0037965955 scopus 로고    scopus 로고
    • Gamma-glutamyltransferase and diabetes - a 4 year follow-up study
    • Lee DH, Ha MH, Kim JH, et al. Gamma-glutamyltransferase and diabetes - a 4 year follow-up study. Diabetologia 2003; 46: 359-64.
    • (2003) Diabetologia , vol.46 , pp. 359-364
    • Lee, D.H.1    Ha, M.H.2    Kim, J.H.3
  • 79
    • 33644693579 scopus 로고    scopus 로고
    • Liver markers and development of the metabolic syndrome: The insulin resistance atherosclerosis study
    • Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Haffner SM. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 2005; 54: 3140-7.
    • (2005) Diabetes , vol.54 , pp. 3140-3147
    • Hanley, A.J.1    Williams, K.2    Festa, A.3    Wagenknecht, L.E.4    D'Agostino, R.B.5    Haffner, S.M.6
  • 80
    • 38749102436 scopus 로고    scopus 로고
    • Liver enzymes and risk of diabetes and cardiovascular disease: Results of the Firenze Bagno a Ripoli (FIBAR) study
    • Monami M, Bardini G, Lamanna C, et al. Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. Metabolism 2008; 57: 387-92.
    • (2008) Metabolism , vol.57 , pp. 387-3892
    • Monami, M.1    Bardini, G.2    Lamanna, C.3
  • 82
    • 48649094475 scopus 로고    scopus 로고
    • Liver enzymes and incident diabetes: Findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study
    • Ford ES, Schulze MB, Bergmann MM, Thamer C, Joost HG, Boeing H. Liver enzymes and incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes Care 2008; 31: 1138-43.
    • (2008) Diabetes Care , vol.31 , pp. 1138-1143
    • Ford, E.S.1    Schulze, M.B.2    Bergmann, M.M.3    Thamer, C.4    Joost, H.G.5    Boeing, H.6
  • 83
    • 65449156905 scopus 로고    scopus 로고
    • NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: An eleven-year follow-up study
    • Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol 2009; 104: 861-7.
    • (2009) Am J Gastroenterol , vol.104 , pp. 861-867
    • Adams, L.A.1    Waters, O.R.2    Knuiman, M.W.3    Elliott, R.R.4    Olynyk, J.K.5
  • 84
    • 65349101599 scopus 로고    scopus 로고
    • Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: The British Women's Heart and Health Study and meta-analysis
    • Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, Lawlor DA. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care. 2009; 32: 741-50.
    • (2009) Diabetes Care , vol.32 , pp. 741-750
    • Fraser, A.1    Harris, R.2    Sattar, N.3    Ebrahim, S.4    Davey, S.G.5    Lawlor, D.A.6
  • 85
    • 77953045389 scopus 로고    scopus 로고
    • Group Study D.E.S.I.R. Nine-year incident diabetes is predicted by fatty liver indices: The French D.E.S.I.R. study
    • Balkau B, Lange C, Vol S, Fumeron F, Bonnet F, Group Study D.E.S.I.R. Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol 2010; 10: 56-66.
    • (2010) BMC Gastroenterol , vol.10 , pp. 56-66
    • Balkau, B.1    Lange, C.2    Vol, S.3    Fumeron, F.4    Bonnet, F.5
  • 87
    • 36048934639 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men
    • Shibata M, Kihara Y, Taguchi M, Tashiro M, Otsuki M. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 2007; 30: 2940-44.
    • (2007) Diabetes Care , vol.30 , pp. 2940-2944
    • Shibata, M.1    Kihara, Y.2    Taguchi, M.3    Tashiro, M.4    Otsuki, M.5
  • 88
    • 41749083027 scopus 로고    scopus 로고
    • Fatty liver is an independent risk factor for the development of type 2 diabetes in Korean adults
    • Kim CH, Park JY, Lee KU, Kim JH, Kim HK. Fatty liver is an independent risk factor for the development of type 2 diabetes in Korean adults. Diabet Med 2008; 25: 476-81.
    • (2008) Diabet Med , vol.25 , pp. 476-481
    • Kim, C.H.1    Park, J.Y.2    Lee, K.U.3    Kim, J.H.4    Kim, H.K.5
  • 89
    • 76149092159 scopus 로고    scopus 로고
    • Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup
    • Yamada T, Fukatsu M, Suzuki S, Wada T, Yoshida T, Joh T. Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup. J Gastroenterol Hepatol 2010; 25: 352-6.
    • (2010) J Gastroenterol Hepatol , vol.25 , pp. 352-356
    • Yamada, T.1    Fukatsu, M.2    Suzuki, S.3    Wada, T.4    Yoshida, T.5    Joh, T.6
  • 90
    • 79953860268 scopus 로고    scopus 로고
    • Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes
    • Sung KC, Kim SH. Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes. J Clin Endocrinol Metab 2011; 96: 1093-97.
    • (2011) J Clin Endocrinol Metab , vol.96 , pp. 1093-1097
    • Sung, K.C.1    Kim, S.H.2
  • 91
    • 79956074978 scopus 로고    scopus 로고
    • Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: A 4-year retrospective longitudinal study
    • Bae JC, Rhee EJ, Lee WY et al. Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study. Diabetes Care 2011; 34: 727-9.
    • (2011) Diabetes Care , vol.34 , pp. 727-729
    • Bae, J.C.1    Rhee, E.J.2    Lee, W.Y.3
  • 92
    • 84862075971 scopus 로고    scopus 로고
    • Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes
    • Sung KC, Jeong WS, Wild SH, Byrne CD. Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes. Diabetes Care 2012; 35: 717-22.
    • (2012) Diabetes Care , vol.35 , pp. 717-722
    • Sung, K.C.1    Jeong, W.S.2    Wild, S.H.3    Byrne, C.D.4
  • 93
    • 84855185039 scopus 로고    scopus 로고
    • Standards of medical care in diabetes - 2012
    • American Diabetes Association
    • American Diabetes Association. Standards of medical care in diabetes - 2012. Diabetes Care 2012; 35 (suppl 1): S11-S63.
    • (2012) Diabetes Care , vol.35 , Issue.1 SUPPL.
  • 94
    • 28844446679 scopus 로고    scopus 로고
    • Hepatic steatosis and insulin resistance: Does etiology make a difference?
    • Lonardo A, Lombardini S, Scaglioni F, et al. Hepatic steatosis and insulin resistance: does etiology make a difference? J Hepatol 2006; 44: 190-6.
    • (2006) J Hepatol , vol.44 , pp. 190-196
    • Lonardo, A.1    Lombardini, S.2    Scaglioni, F.3
  • 95
    • 46049089412 scopus 로고    scopus 로고
    • Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes
    • Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology 2008; 135: 122-30.
    • (2008) Gastroenterology , vol.135 , pp. 122-130
    • Kotronen, A.1    Juurinen, L.2    Tiikkainen, M.3    Vehkavaara, S.4    Yki-Järvinen, H.5
  • 96
    • 80053627289 scopus 로고    scopus 로고
    • Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
    • Kumashiro N, Erion DM, Zhang D, et al. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci USA 2011; 108: 16381-5.
    • (2011) Proc Natl Acad Sci USA , vol.108 , pp. 16381-16385
    • Kumashiro, N.1    Erion, D.M.2    Zhang, D.3
  • 97
    • 77956404177 scopus 로고    scopus 로고
    • Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection
    • de Meijer VE, Kalish BT, Puder M, Ijzermans JN. Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg 2010; 97: 1331-9.
    • (2010) Br J Surg , vol.97 , pp. 1331-1339
    • de Meijer, V.E.1    Kalish, B.T.2    Puder, M.3    Ijzermans, J.N.4
  • 98
    • 0242695768 scopus 로고    scopus 로고
    • One thousand fifty-six hepatectomies without mortality in 8 years
    • Imamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003; 138: 1198-206.
    • (2003) Arch Surg , vol.138 , pp. 1198-1206
    • Imamura, H.1    Seyama, Y.2    Kokudo, N.3
  • 99
    • 36549063731 scopus 로고    scopus 로고
    • Use of severely steatotic grafts in liver transplantation: A matched case-control study
    • McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg 2007; 246: 940-46.
    • (2007) Ann Surg , vol.246 , pp. 940-946
    • McCormack, L.1    Petrowsky, H.2    Jochum, W.3    Mullhaupt, B.4    Weber, M.5    Clavien, P.A.6
  • 100
    • 84895068906 scopus 로고    scopus 로고
    • Underlying steatohepatitis, but not simple steatosis, increases morbidity after liver resection: A case-control study
    • Reddy SK, Marsh JW, Varley PR, et al. Underlying steatohepatitis, but not simple steatosis, increases morbidity after liver resection: a case-control study. Hepatology 2012; 56: 221-30
    • (2012) Hepatology , vol.56 , pp. 221-230
    • Reddy, S.K.1    Marsh, J.W.2    Varley, P.R.3
  • 101
    • 33845948392 scopus 로고    scopus 로고
    • Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy
    • Veteläinen R, van Vliet AK, van Gulik TM. Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy. Ann Surg 2007; 245: 44-50.
    • (2007) Ann Surg , vol.245 , pp. 44-50
    • Veteläinen, R.1    van Vliet, A.K.2    van Gulik, T.M.3
  • 102
    • 0032828612 scopus 로고    scopus 로고
    • Fatty liver and nonalcoholic steatohepatitis. Where do we stand and where are we going
    • Lonardo A. Fatty liver and nonalcoholic steatohepatitis. Where do we stand and where are we going? Dig Dis 1999; 17: 80-89.
    • (1999) Dig Dis , vol.17 , pp. 80-89
    • Lonardo, A.1
  • 103
    • 0035431018 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: A feature of the metabolic syndrome
    • Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-50.
    • (2001) Diabetes , vol.50 , pp. 1844-1850
    • Marchesini, G.1    Brizi, M.2    Bianchi, G.3
  • 104
  • 106
    • 77049312542 scopus 로고
    • Action of lipotropic factors in experimental cholesterol arteriosclerosis in rabbits. II. Action of anti-fatty liver factor
    • De Fazio V, Marsico F. Action of lipotropic factors in experimental cholesterol arteriosclerosis in rabbits. II. Action of anti-fatty liver factor. Riv Ist Sieroter Ital 1950; 25: 118-24.
    • (1950) Riv Ist Sieroter Ital , vol.25 , pp. 118-124
    • de Fazio, V.1    Marsico, F.2
  • 107
    • 50849096389 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review
    • Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol 2008; 49: 600-7.
    • (2008) J Hepatol , vol.49 , pp. 600-607
    • Sookoian, S.1    Pirola, C.J.2
  • 108
    • 84861417701 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease: A new and important cardiovascular risk factor?
    • Bhatia LS, Curzen NP, Calder PC, Byrne CD. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J 2012; 33: 1190-200.
    • (2012) Eur Heart J , vol.33 , pp. 1190-1200
    • Bhatia, L.S.1    Curzen, N.P.2    Calder, P.C.3    Byrne, C.D.4
  • 109
    • 0042265627 scopus 로고    scopus 로고
    • Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E
    • Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 2003; 38: 413-9.
    • (2003) Hepatology , vol.38 , pp. 413-419
    • Kugelmas, M.1    Hill, D.B.2    Vivian, B.3    Marsano, L.4    McClain, C.J.5
  • 110
    • 2342462456 scopus 로고    scopus 로고
    • High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD
    • Hui JM, Farrell GC, Kench JG, George J. High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD. Hepatology 2004; 39: 1458-9.
    • (2004) Hepatology , vol.39 , pp. 1458-1459
    • Hui, J.M.1    Farrell, G.C.2    Kench, J.G.3    George, J.4
  • 111
    • 4444382031 scopus 로고    scopus 로고
    • Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis
    • Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004; 99: 1497-502.
    • (2004) Am J Gastroenterol , vol.99 , pp. 1497-1502
    • Chalasani, N.1    Deeg, M.A.2    Crabb, D.W.3
  • 112
    • 33646161443 scopus 로고    scopus 로고
    • Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
    • Haukeland JW, Damas JK, Konopski Z, et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol 2006; 44: 1167-74.
    • (2006) J Hepatol , vol.44 , pp. 1167-1174
    • Haukeland, J.W.1    Damas, J.K.2    Konopski, Z.3
  • 113
    • 25844445415 scopus 로고    scopus 로고
    • Nonalcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in nondiabetic men. Role of visceral adipose tissue
    • Targher G, Bertolini L, Scala L, Zoppini G, Zenari L, Falezza G. Nonalcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in nondiabetic men. Role of visceral adipose tissue. Diabet Med 2005; 22: 1354-8.
    • (2005) Diabet Med , vol.22 , pp. 1354-1358
    • Targher, G.1    Bertolini, L.2    Scala, L.3    Zoppini, G.4    Zenari, L.5    Falezza, G.6
  • 114
    • 44449109670 scopus 로고    scopus 로고
    • NASH predicts plasma inflammatory biomarkers independently of visceral fat in men
    • Targher G, Bertolini L, Rodella S, et al. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity (Silver Spring) 2008; 16: 1394-9.
    • (2008) Obesity (Silver Spring) , vol.16 , pp. 1394-1399
    • Targher, G.1    Bertolini, L.2    Rodella, S.3
  • 115
    • 34548804940 scopus 로고    scopus 로고
    • Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: Possible role of vitamin A intake
    • Musso G, Gambino R, De MF, et al. Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake. Am J Clin Nutr 2007; 86: 661-71.
    • (2007) Am J Clin Nutr , vol.86 , pp. 661-671
    • Musso, G.1    Gambino, R.2    De, M.F.3
  • 116
    • 67349256422 scopus 로고    scopus 로고
    • Retinol-binding protein 4: A promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease
    • Nobili V, Alkhouri N, Alisi A, et al. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009; 7: 575-9.
    • (2009) Clin Gastroenterol Hepatol , vol.7 , pp. 575-579
    • Nobili, V.1    Alkhouri, N.2    Alisi, A.3
  • 117
    • 68949111875 scopus 로고    scopus 로고
    • Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease
    • Milner KL, van der Poorten D, Xu A, et al. Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. Hepatology 2009; 49: 1926-34.
    • (2009) Hepatology , vol.49 , pp. 1926-1934
    • Milner, K.L.1    van der Poorten, D.2    Xu, A.3
  • 118
    • 77950017450 scopus 로고    scopus 로고
    • Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease
    • Sookoian S, Castano GO, Burgueno AL, et al. Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease. Atherosclerosis 2010; 209: 585-91.
    • (2010) Atherosclerosis , vol.209 , pp. 585-591
    • Sookoian, S.1    Castano, G.O.2    Burgueno, A.L.3
  • 119
    • 79960212414 scopus 로고    scopus 로고
    • Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease
    • Yilmaz Y, Kurt R, Gurdal A, et al. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. Atherosclerosis 2011; 217: 125-9.
    • (2011) Atherosclerosis , vol.217 , pp. 125-129
    • Yilmaz, Y.1    Kurt, R.2    Gurdal, A.3
  • 120
    • 78650777773 scopus 로고    scopus 로고
    • Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease
    • Kotronen A, Joutsi-Korhonen L, Sevastianova K, et al. Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease. Liver Int 2011; 31: 176-83.
    • (2011) Liver Int , vol.31 , pp. 176-183
    • Kotronen, A.1    Joutsi-Korhonen, L.2    Sevastianova, K.3
  • 121
    • 84865563631 scopus 로고    scopus 로고
    • Cardiovascular phenotype of nonalcoholic fatty liver disease: Changing the paradigm about the role of distant toxic fat accumulation on vascular disease
    • Sookoian S, Castano GO, Pirola CJ. Cardiovascular phenotype of nonalcoholic fatty liver disease: changing the paradigm about the role of distant toxic fat accumulation on vascular disease. Hepatology 2012; 1185-86.
    • (2012) Hepatology , pp. 1185-1186
    • Sookoian, S.1    Castano, G.O.2    Pirola, C.J.3
  • 122
    • 84155174986 scopus 로고    scopus 로고
    • Mean platelet volume as a marker of increased cardiovascular risk in patients with nonalcoholic steatohepatitis
    • Alkhouri N, Kistangari G, Campbell C, Lopez R, Zein NN, Feldstein AE. Mean platelet volume as a marker of increased cardiovascular risk in patients with nonalcoholic steatohepatitis. Hepatology 2012; 55: 331.
    • (2012) Hepatology , vol.55 , pp. 331
    • Alkhouri, N.1    Kistangari, G.2    Campbell, C.3    Lopez, R.4    Zein, N.N.5    Feldstein, A.E.6
  • 123
    • 80051552944 scopus 로고    scopus 로고
    • Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation
    • Ndumele CE, Nasir K, Conceicao RD, Carvalho JA, Blumenthal RS, Santos RD. Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation. Arterioscler Thromb Vasc Biol 2011; 31: 1927-32.
    • (2011) Arterioscler Thromb Vasc Biol , vol.31 , pp. 1927-1932
    • Ndumele, C.E.1    Nasir, K.2    Conceicao, R.D.3    Carvalho, J.A.4    Blumenthal, R.S.5    Santos, R.D.6
  • 124
    • 72549099600 scopus 로고    scopus 로고
    • Haemoglobin and nonalcoholic fatty liver disease: Further evidence from a populationbased study
    • Xu L, Xu CF, Yu CH, Miao M, Li YM. Haemoglobin and nonalcoholic fatty liver disease: further evidence from a populationbased study. Gut 2009; 58: 1706-7.
    • (2009) Gut , vol.58 , pp. 1706-1707
    • Xu, L.1    Xu, C.F.2    Yu, C.H.3    Miao, M.4    Li, Y.M.5
  • 125
    • 84858284683 scopus 로고    scopus 로고
    • Characterization of nonalcoholic fatty liver disease unrelated to metabolic syndrome
    • Yilmaz Y, Senates E, Ayyildiz T, et al. Characterization of nonalcoholic fatty liver disease unrelated to metabolic syndrome. Eur J Clin Invest 2012; 42: 411-8.
    • (2012) Eur J Clin Invest , vol.42 , pp. 411-418
    • Yilmaz, Y.1    Senates, E.2    Ayyildiz, T.3
  • 128
    • 34547596738 scopus 로고    scopus 로고
    • High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH
    • Yoneda M, Mawatari H, Fujita K, et al. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol 2007; 42: 573-82.
    • (2007) J Gastroenterol , vol.42 , pp. 573-582
    • Yoneda, M.1    Mawatari, H.2    Fujita, K.3
  • 129
    • 49449083979 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake
    • Thuy S, Ladurner R, Volynets V, et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 2008; 138: 1452-5.
    • (2008) J Nutr , vol.138 , pp. 1452-1455
    • Thuy, S.1    Ladurner, R.2    Volynets, V.3
  • 130
    • 35748972366 scopus 로고    scopus 로고
    • Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects
    • Westerbacka J, Kolak M, Kiviluoto T, et al. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 2007; 56: 2759-65.
    • (2007) Diabetes , vol.56 , pp. 2759-2765
    • Westerbacka, J.1    Kolak, M.2    Kiviluoto, T.3
  • 132
    • 84862279461 scopus 로고    scopus 로고
    • Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease
    • Chiang CH, Huang PH, Chung FP, et al. Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease. PLoSOne 2012; 7: e31799.
    • (2012) PLoSOne , vol.7
    • Chiang, C.H.1    Huang, P.H.2    Chung, F.P.3
  • 133
    • 33746421488 scopus 로고    scopus 로고
    • Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease
    • Targher G, Bertolini L, Padovani R, et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006; 29: 1325-30.
    • (2006) Diabetes Care , vol.29 , pp. 1325-1330
    • Targher, G.1    Bertolini, L.2    Padovani, R.3
  • 134
    • 84872339818 scopus 로고    scopus 로고
    • Assessment of endothelial function in patients with nonalcoholic fatty liver disease
    • Colak Y, Senates E, Yesil A, et al. Assessment of endothelial function in patients with nonalcoholic fatty liver disease. Endocrine. 2013; 43: 100-7.
    • (2013) Endocrine , vol.43 , pp. 100-107
    • Colak, Y.1    Senates, E.2    Yesil, A.3
  • 135
    • 84859954406 scopus 로고    scopus 로고
    • Fatty liver index, gamma-glutamyltransferase, and early carotid plaques
    • RISC Investigators
    • Kozakova M, Palombo C, Eng MP, et at; RISC Investigators. Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. Hepatology. 2012; 55: 1406-15.
    • (2012) Hepatology , vol.55 , pp. 1406-1415
    • Kozakova, M.1    Palombo, C.2    Eng, M.P.3
  • 136
    • 66149119340 scopus 로고    scopus 로고
    • Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population
    • Gastaldelli A, Kozakova M, Hojlund K, et al. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 2009; 49: 1537-44.
    • (2009) Hepatology , vol.49 , pp. 1537-1544
    • Gastaldelli, A.1    Kozakova, M.2    Hojlund, K.3
  • 137
    • 84875210688 scopus 로고    scopus 로고
    • The severity of fatty liver disease relating to metabolic abnormalities independently predicts coronary calcification
    • Lee YH, Wu YJ, Liu CC, et al. The severity of fatty liver disease relating to metabolic abnormalities independently predicts coronary calcification. Radiol Res Pract 2011; 2011: 586785.
    • (2011) Radiol Res Pract , pp. 586785
    • Lee, Y.H.1    Wu, Y.J.2    Liu, C.C.3
  • 138
    • 77954423206 scopus 로고    scopus 로고
    • Association between nonalcoholic fatty liver disease and coronary artery calcification
    • Chen CH, Nien CK, Yang CC, Yeh YH. Association between nonalcoholic fatty liver disease and coronary artery calcification. Dig Dis Sci 2010; 55: 1752-60.
    • (2010) Dig Dis Sci , vol.55 , pp. 1752-1760
    • Chen, C.H.1    Nien, C.K.2    Yang, C.C.3    Yeh, Y.H.4
  • 139
    • 84864360646 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease is associated with coronary artery calcification
    • Kim D, Choi SY, Park EH, et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology 2012; 56: 605-13.
    • (2012) Hepatology , vol.56 , pp. 605-613
    • Kim, D.1    Choi, S.Y.2    Park, E.H.3
  • 140
    • 84868141067 scopus 로고    scopus 로고
    • Fatty liver, insulin resistance and features of metabolic syndrome: Relationships with coronary artery calcium in 10153 people
    • Sung KC, Wild SH, Kwag HJ, Byrne CD. Fatty liver, insulin resistance and features of metabolic syndrome: relationships with coronary artery calcium in 10153 people. Diabetes Care 2012; 35: 2359-64.
    • (2012) Diabetes Care , vol.35 , pp. 2359-2364
    • Sung, K.C.1    Wild, S.H.2    Kwag, H.J.3    Byrne, C.D.4
  • 141
    • 43549095894 scopus 로고    scopus 로고
    • Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT)
    • Akabame S, Hamaguchi M, Tomiyasu K, et al. Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT). Circ J 2008; 72: 618-25.
    • (2008) Circ J , vol.72 , pp. 618-625
    • Akabame, S.1    Hamaguchi, M.2    Tomiyasu, K.3
  • 142
    • 77449127455 scopus 로고    scopus 로고
    • Presence of coronary plaques in patients with nonalcoholic fatty liver disease
    • Assy N, Djibre A, Farah R, Grosovski M, Marmor A. Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology 2010; 254: 393-400.
    • (2010) Radiology , vol.254 , pp. 393-400
    • Assy, N.1    Djibre, A.2    Farah, R.3    Grosovski, M.4    Marmor, A.5
  • 143
    • 80655144446 scopus 로고    scopus 로고
    • Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease
    • Wong VW, Wong GL, Yip GW, et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut 2011; 60: 1721-27.
    • (2011) Gut , vol.60 , pp. 1721-1727
    • Wong, V.W.1    Wong, G.L.2    Yip, G.W.3
  • 144
    • 77954315951 scopus 로고    scopus 로고
    • Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: Association with liver fibrosis
    • Yilmaz Y, Kurt R, Yonal O, et al. Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis. Atherosclerosis 2010; 211: 182-86.
    • (2010) Atherosclerosis , vol.211 , pp. 182-186
    • Yilmaz, Y.1    Kurt, R.2    Yonal, O.3
  • 145
    • 34247605492 scopus 로고    scopus 로고
    • Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients
    • Targher G, Bertolini L, Padovani R, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 30: 1212-18.
    • (2007) Diabetes Care , vol.30 , pp. 1212-1218
    • Targher, G.1    Bertolini, L.2    Padovani, R.3
  • 146
    • 24044476188 scopus 로고    scopus 로고
    • Sonographic fatty liver, overweight and ischemic heart disease
    • Lin YC, Lo HM, Chen JD. Sonographic fatty liver, overweight and ischemic heart disease. World J Gastroenterol 2005; 11: 4838-42.
    • (2005) World J Gastroenterol , vol.11 , pp. 4838-4842
    • Lin, Y.C.1    Lo, H.M.2    Chen, J.D.3
  • 147
    • 49149114288 scopus 로고    scopus 로고
    • Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease
    • Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation 2008; 118: 277-83.
    • (2008) Circulation , vol.118 , pp. 277-283
    • Schwimmer, J.B.1    Pardee, P.E.2    Lavine, J.E.3    Blumkin, A.K.4    Cook, S.5
  • 148
    • 78049523237 scopus 로고    scopus 로고
    • Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease
    • Pacifico L, Anania C, Martino F, et al. Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease. Hepatology 2010; 52: 1643-51.
    • (2010) Hepatology , vol.52 , pp. 1643-1651
    • Pacifico, L.1    Anania, C.2    Martino, F.3
  • 149
    • 79959453955 scopus 로고    scopus 로고
    • Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease
    • Alkhouri N, Carter-Kent C, Elias M, Feldstein AE. Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease. Clin Lipidol 2011 1; 6: 305-14.
    • Clin Lipidol , vol.1-6 , pp. 305-314
    • Alkhouri, N.1    Carter-Kent, C.2    Elias, M.3    Feldstein, A.E.4
  • 150
    • 77958091760 scopus 로고    scopus 로고
    • Increased arterial stiffness and impaired endothelial function in nonalcoholic fatty liver disease: A pilot study
    • Vlachopoulos C, Manesis E, Baou K, et al. Increased arterial stiffness and impaired endothelial function in nonalcoholic fatty liver disease: a pilot study. Am J Hypertens 2010; 23: 1183-9.
    • (2010) Am J Hypertens , vol.23 , pp. 1183-1189
    • Vlachopoulos, C.1    Manesis, E.2    Baou, K.3
  • 151
    • 77954951936 scopus 로고    scopus 로고
    • Increased arterial stiffness in nonalcoholic fatty liver disease: The Cardio-GOOSE study
    • Salvi P, Ruffini R, Agnoletti D, et al. Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study. J Hypertens 2010; 28: 1699-707.
    • (2010) J Hypertens , vol.28 , pp. 1699-1707
    • Salvi, P.1    Ruffini, R.2    Agnoletti, D.3
  • 152
    • 84856708597 scopus 로고    scopus 로고
    • The relationship between arterial stiffness and nonalcoholic fatty liver disease
    • Lee YJ, Shim JY, Moon BS, et al. The relationship between arterial stiffness and nonalcoholic fatty liver disease. Dig Dis Sci 2012; 57: 196-203.
    • (2012) Dig Dis Sci , vol.57 , pp. 196-203
    • Lee, Y.J.1    Shim, J.Y.2    Moon, B.S.3
  • 153
    • 23044512117 scopus 로고    scopus 로고
    • Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease
    • Villanova N, Moscatiello S, Ramilli S, et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005; 42: 473-80.
    • (2005) Hepatology , vol.42 , pp. 473-480
    • Villanova, N.1    Moscatiello, S.2    Ramilli, S.3
  • 154
    • 38649091680 scopus 로고    scopus 로고
    • Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver
    • Perseghin G, Lattuada G, De CF, et al. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver. Hepatology 2008; 47: 51-58.
    • (2008) Hepatology , vol.47 , pp. 51-58
    • Perseghin, G.1    Lattuada, G.2    De, C.F.3
  • 155
    • 33745856570 scopus 로고    scopus 로고
    • Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes
    • Lautamaki R, Borra R, Iozzo P, et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am J Physiol Endocrinol Metab 2006; 291: E282-90.
    • (2006) Am J Physiol Endocrinol Metab , vol.291 , pp. 282-290
    • Lautamaki, R.1    Borra, R.2    Iozzo, P.3
  • 156
    • 77955060310 scopus 로고    scopus 로고
    • Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes
    • Rijzewijk LJ, Jonker JT, van der Meer RW, et al. Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes. J Am Coll Cardiol 2010; 56: 225-33.
    • (2010) J Am Coll Cardiol , vol.56 , pp. 225-233
    • Rijzewijk, L.J.1    Jonker, J.T.2    van der Meer, R.W.3
  • 157
    • 33750630075 scopus 로고    scopus 로고
    • Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: Echocardiographic and tissue Doppler imaging assessment
    • Goland S, Shimoni S, Zornitzki T, et al. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. J Clin Gastroenterol 2006; 40: 949-55.
    • (2006) J Clin Gastroenterol , vol.40 , pp. 949-955
    • Goland, S.1    Shimoni, S.2    Zornitzki, T.3
  • 158
    • 77957954467 scopus 로고    scopus 로고
    • Impairment of the left ventricular systolic and diastolic function in patients with nonalcoholic fatty liver disease
    • Fotbolcu H, Yakar T, Duman D, et al. Impairment of the left ventricular systolic and diastolic function in patients with nonalcoholic fatty liver disease. Cardiol J 2010; 17: 457-63.
    • (2010) Cardiol J , vol.17 , pp. 457-463
    • Fotbolcu, H.1    Yakar, T.2    Duman, D.3
  • 159
    • 70349482410 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension
    • Fallo F, Dalla PA, Sonino N, et al. Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. Nutr Metab Cardiovasc Dis 2009; 19: 646-53.
    • (2009) Nutr Metab Cardiovasc Dis , vol.19 , pp. 646-653
    • Fallo, F.1    Dalla, P.A.2    Sonino, N.3
  • 160
    • 84859048319 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes
    • Bonapace S, Perseghin G, Molon G, et al. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care 2012; 35: 389-95.
    • (2012) Diabetes Care , vol.35 , pp. 389-395
    • Bonapace, S.1    Perseghin, G.2    Molon, G.3
  • 161
    • 84861189807 scopus 로고    scopus 로고
    • Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease
    • Colak Y, Karabay CY, Tuncer I, et al. Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2012; 24: 613-8.
    • (2012) Eur J Gastroenterol Hepatol , vol.24 , pp. 613-618
    • Colak, Y.1    Karabay, C.Y.2    Tuncer, I.3
  • 162
    • 77952529040 scopus 로고    scopus 로고
    • A position statement on NAFLD/NASH based on the EASL 2009 special conference
    • Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010; 53: 372-84.
    • (2010) J Hepatol , vol.53 , pp. 372-384
    • Ratziu, V.1    Bellentani, S.2    Cortez-Pinto, H.3    Day, C.4    Marchesini, G.5
  • 163
    • 84861329163 scopus 로고    scopus 로고
    • Independent Association between nonalcoholic fatty liver disease and cardiovascular disease in the US Population
    • Stepanova M, Younossi ZM. Independent Association between nonalcoholic fatty liver disease and cardiovascular disease in the US Population. Clin Gastroenterol Hepatol. 2012; 10: 646-50.
    • (2012) Clin Gastroenterol Hepatol , vol.10 , pp. 646-650
    • Stepanova, M.1    Younossi, Z.M.2
  • 164
    • 84859912969 scopus 로고    scopus 로고
    • Cardiovascular disease and nonalcoholic fatty liver disease: Does histologic severity matter?
    • Domanski JP, Park SJ, Harrison SA. Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter? J Clin Gastroenterol 2012; 46: 427-30.
    • (2012) J Clin Gastroenterol , vol.46 , pp. 427-430
    • Domanski, J.P.1    Park, S.J.2    Harrison, S.A.3
  • 165
    • 62649107835 scopus 로고    scopus 로고
    • The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects
    • Sung KC, Ryan MC, Wilson AM. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects. Atherosclerosis 2009; 203: 581-6.
    • (2009) Atherosclerosis , vol.203 , pp. 581-586
    • Sung, K.C.1    Ryan, M.C.2    Wilson, A.M.3
  • 166
    • 33644700376 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients
    • Targher G, Bertolini L, Poli F, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005; 54: 3541-6
    • (2005) Diabetes , vol.54 , pp. 3541-3546
    • Targher, G.1    Bertolini, L.2    Poli, F.3
  • 167
    • 34547673500 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients
    • Targher G, Bertolini L, Rodella S, et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 2007; 30: 2119-21.
    • (2007) Diabetes Care , vol.30 , pp. 2119-2121
    • Targher, G.1    Bertolini, L.2    Rodella, S.3
  • 168
    • 34247647418 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
    • Hamaguchi M, Kojima T, Takeda N, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007; 13: 1579-84.
    • (2007) World J Gastroenterol , vol.13 , pp. 1579-1584
    • Hamaguchi, M.1    Kojima, T.2    Takeda, N.3
  • 169
    • 84863148823 scopus 로고    scopus 로고
    • Natural course of nonalcoholic fatty liver disease in southern China: A prospective cohort study
    • Zhou YJ, Li YY, Nie YQ, Huang CM, Cao CY. Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study. J Dig Dis 2012; 13: 153-60.
    • (2012) J Dig Dis , vol.13 , pp. 153-160
    • Zhou, Y.J.1    Li, Y.Y.2    Nie, Y.Q.3    Huang, C.M.4    Cao, C.Y.5
  • 170
    • 80052741269 scopus 로고    scopus 로고
    • Treatment of atherogenic liver based on the pathogenesis of nonalcoholic fatty liver disease: A novel approach to reduce cardiovascular risk?
    • Maurantonio M, Ballestri S, Odoardi MR, Lonardo A, Loria P. Treatment of atherogenic liver based on the pathogenesis of nonalcoholic fatty liver disease: a novel approach to reduce cardiovascular risk? Arch Med Res 2011; 42: 337-53.
    • (2011) Arch Med Res , vol.42 , pp. 337-353
    • Maurantonio, M.1    Ballestri, S.2    Odoardi, M.R.3    Lonardo, A.4    Loria, P.5
  • 171
    • 79954662342 scopus 로고    scopus 로고
    • Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?
    • Targher G, Chonchol M, Zoppini G, Abaterusso C, Bonora E. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? J Hepatol 2011; 54: 1020-9.
    • (2011) J Hepatol , vol.54 , pp. 1020-1029
    • Targher, G.1    Chonchol, M.2    Zoppini, G.3    Abaterusso, C.4    Bonora, E.5
  • 172
    • 39049102073 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients
    • Targher G, Bertolini L, Rodella S, et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia 2008; 51: 444-50.
    • (2008) Diabetologia , vol.51 , pp. 444-450
    • Targher, G.1    Bertolini, L.2    Rodella, S.3
  • 173
    • 84855812468 scopus 로고    scopus 로고
    • Increased prevalence of chronic kidney disease in patients with type 1 diabetes and non-alcoholic fatty liver
    • Targher G, Pichiri I, Zoppini G, Trombetta M, Bonora E. Increased prevalence of chronic kidney disease in patients with type 1 diabetes and non-alcoholic fatty liver. Diabet Med 2012; 29: 220-6.
    • (2012) Diabet Med , vol.29 , pp. 220-226
    • Targher, G.1    Pichiri, I.2    Zoppini, G.3    Trombetta, M.4    Bonora, E.5
  • 174
    • 77953838107 scopus 로고    scopus 로고
    • Impact of NAFLD on microalbuminuria in patients with prediabetes and diabetes
    • Hwang ST, Cho YK, Yun JW, et al. Impact of NAFLD on microalbuminuria in patients with prediabetes and diabetes. Intern Med J 2010; 40: 437-42.
    • (2010) Intern Med J , vol.40 , pp. 437-442
    • Hwang, S.T.1    Cho, Y.K.2    Yun, J.W.3
  • 175
    • 77955654684 scopus 로고    scopus 로고
    • Relationship between serum gamma-glutamyltransferase concentrations and chronic kidney disease in the United States population
    • Findings, from the National Health and Nutrition Examination Survey 2001-2006
    • Targher G, Kendrick J, Smits G, Chonchol M. Relationship between serum gamma-glutamyltransferase concentrations and chronic kidney disease in the United States population. Findings from the National Health and Nutrition Examination Survey 2001-2006. Nutr Metab Cardiovasc Dis 2010; 20: 583-90.
    • (2010) Nutr Metab Cardiovasc Dis , vol.20 , pp. 583-590
    • Targher, G.1    Kendrick, J.2    Smits, G.3    Chonchol, M.4
  • 176
    • 77956625813 scopus 로고    scopus 로고
    • Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: Association with liver fibrosis
    • Yilmaz Y, Alahdab YO, Yonal O, et al. Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis. Metabolism 2010; 59: 1327-30.
    • (2010) Metabolism , vol.59 , pp. 1327-1330
    • Yilmaz, Y.1    Alahdab, Y.O.2    Yonal, O.3
  • 177
    • 78650323871 scopus 로고    scopus 로고
    • Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis
    • Targher G, Chonchol M, Bertolini L, et al. Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin J Am Soc Nephrol 2010; 5: 2166-71.
    • (2010) Clin J Am Soc Nephrol , vol.5 , pp. 2166-2171
    • Targher, G.1    Chonchol, M.2    Bertolini, L.3
  • 178
    • 23444432659 scopus 로고    scopus 로고
    • Serum gammaglutamyltransferase was differently associated with microalbuminuria by status of hypertension and diabetes: The Coronary Artery Risk Development in Young Adults (CARDIA) study
    • Lee DH, Jacobs DR, Gross M, Steffes M. Serum gammaglutamyltransferase was differently associated with microalbuminuria by status of hypertension and diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Clin Chem 2005; 51: 1185-91.
    • (2005) Clin Chem , vol.51 , pp. 1185-1191
    • Lee, D.H.1    Jacobs, D.R.2    Gross, M.3    Steffes, M.4
  • 179
    • 33846007117 scopus 로고    scopus 로고
    • Gammaglutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men
    • Ryu S, Chang Y, Kim DI, Kim WS, Suh BS. Gammaglutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem 2007; 53: 71-7.
    • (2007) Clin Chem , vol.53 , pp. 71-77
    • Ryu, S.1    Chang, Y.2    Kim, D.I.3    Kim, W.S.4    Suh, B.S.5
  • 180
    • 40049095342 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men
    • Chang Y, Ryu S, Sung E, et al. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism 2008; 57: 569-76.
    • (2008) Metabolism , vol.57 , pp. 569-576
    • Chang, Y.1    Ryu, S.2    Sung, E.3
  • 181
    • 49649090452 scopus 로고    scopus 로고
    • Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease
    • Targher G, Chonchol M, Bertolini L, et al. Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol 2008; 19: 1564-70.
    • (2008) J Am Soc Nephrol , vol.19 , pp. 1564-1570
    • Targher, G.1    Chonchol, M.2    Bertolini, L.3
  • 182
    • 70350443275 scopus 로고    scopus 로고
    • Transdifferentiation properties of adipocytes in the adipose organ
    • Cinti S. Transdifferentiation properties of adipocytes in the adipose organ. Am J Physiol Endocrinol Metab 2009; 297: E977-86.
    • (2009) Am J Physiol Endocrinol Metab , vol.297 , pp. 977-986
    • Cinti, S.1
  • 183
    • 84856604266 scopus 로고    scopus 로고
    • Targeting the renin-angiotensin system: Potential beneficial effects of the angiotensin II receptor blockers in patients with nonalcoholic steatohepatitis
    • Sookoian S, Pirola CJ. Targeting the renin-angiotensin system: potential beneficial effects of the angiotensin II receptor blockers in patients with nonalcoholic steatohepatitis. Hepatology 2011; 54: 2276-77.
    • (2011) Hepatology , vol.54 , pp. 2276-2277
    • Sookoian, S.1    Pirola, C.J.2
  • 184
    • 0027267328 scopus 로고
    • Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function
    • Ridker PM, Gaboury CL, Conlin PR, Seely EW, Williams GH, Vaughan DE. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation 1993; 87: 1969-73.
    • (1993) Circulation , vol.87 , pp. 1969-1973
    • Ridker, P.M.1    Gaboury, C.L.2    Conlin, P.R.3    Seely, E.W.4    Williams, G.H.5    Vaughan, D.E.6
  • 185
    • 0342378176 scopus 로고    scopus 로고
    • Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin
    • Grafe M, Auch-Schwelk W, Zakrzewicz A, et al. Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin. Circ Res 1997; 81: 804-11.
    • (1997) Circ Res , vol.81 , pp. 804-811
    • Grafe, M.1    Auch-Schwelk, W.2    Zakrzewicz, A.3
  • 186
    • 0032832989 scopus 로고    scopus 로고
    • Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo
    • Pastore L, Tessitore A, Martinotti S, et al. Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation 1999; 100: 1646-52.
    • (1999) Circulation , vol.100 , pp. 1646-1652
    • Pastore, L.1    Tessitore, A.2    Martinotti, S.3
  • 187
    • 68949203694 scopus 로고    scopus 로고
    • Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model
    • Rosselli MS, Burgueno AL, Carabelli J, Schuman M, Pirola CJ, Sookoian S. Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model. Atherosclerosis 2009; 206: 119-26.
    • (2009) Atherosclerosis , vol.206 , pp. 119-126
    • Rosselli, M.S.1    Burgueno, A.L.2    Carabelli, J.3    Schuman, M.4    Pirola, C.J.5    Sookoian, S.6
  • 188
    • 84862517200 scopus 로고    scopus 로고
    • Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of randomised trials
    • Musso G, Cassader M, Rosina F, Gambino R. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 2012; 55: 885-904.
    • (2012) Diabetologia , vol.55 , pp. 885-904
    • Musso, G.1    Cassader, M.2    Rosina, F.3    Gambino, R.4
  • 189
    • 79959722134 scopus 로고    scopus 로고
    • All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population
    • El-Kamary SS, Jhaveri R, Shardell MD. All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population. Clin Infect Dis 2011; 53: 150-7.
    • (2011) Clin Infect Dis , vol.53 , pp. 150-157
    • El-Kamary, S.S.1    Jhaveri, R.2    Shardell, M.D.3
  • 190
    • 84858707788 scopus 로고    scopus 로고
    • Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis
    • Adinolfi LE, Restivo L, Zampino R, et al. Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis. Atherosclerosis 2012; 221: 496-502.
    • (2012) Atherosclerosis , vol.221 , pp. 496-502
    • Adinolfi, L.E.1    Restivo, L.2    Zampino, R.3
  • 191
    • 84857710351 scopus 로고    scopus 로고
    • Atherosclerosis in chronic kidney disease: Lessons learned from glycation in diabetes
    • Mohar DS, Barseghian A, Haider N, Domanski M, Narula J. Atherosclerosis in chronic kidney disease: lessons learned from glycation in diabetes. Med Clin North Am 2012; 96: 57-65.
    • (2012) Med Clin North Am , vol.96 , pp. 57-65
    • Mohar, D.S.1    Barseghian, A.2    Haider, N.3    Domanski, M.4    Narula, J.5
  • 192
    • 84859270441 scopus 로고    scopus 로고
    • Relation between estimated glomerular filtration rate and composition of coronary arterial atherosclerotic plaques
    • Hayano S, Ichimiya S, Ishii H, et al. Relation between estimated glomerular filtration rate and composition of coronary arterial atherosclerotic plaques. Am J Cardiol 2012; 109: 1131-6.
    • (2012) Am J Cardiol , vol.109 , pp. 1131-1136
    • Hayano, S.1    Ichimiya, S.2    Ishii, H.3
  • 193
    • 84863489710 scopus 로고    scopus 로고
    • Increased risk of cardiovascular disease and chronic kidney disease in NAFLD
    • Bonora E, Targher G. Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. Nat Rev Gastroenterol Hepatol 2012; 9: 372-81.
    • (2012) Nat Rev Gastroenterol Hepatol , vol.9 , pp. 372-381
    • Bonora, E.1    Targher, G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.